Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies | Patent Publication Number 20160095908

US 20160095908 A1
Patent Number-
Application Number14966759
Filled DateDec 11, 2015
Priority DateJun 14, 2005
Publication DateApr 7, 2016
Original Assignee
Current AssigneeRevance Therapeutics
Inventor/ApplicantsGary E. Borodic
Martin Acquadro
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.